Pub Date : 2025-11-01DOI: 10.1097/OGX.0000000000001463
Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck
(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.
{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"https://doi.org/10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/OGX.0000000000001463
Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck
(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.
{"title":"A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.","authors":"Yogish C Kudva, Dan Raghinaru, John W Lum, Timothy E Graham, David Liljenquist, Elias K Spanakis, Francisco J Pasquel, Andrew Ahmann, David T Ahn, Grazia Aleppo, Thomas Blevins, Davida Kruger, Sue A Brown, Carol J Levy, Ruth S Weinstock, Devin W Steenkamp, Tamara Spaic, Irl B Hirsch, Frances Broyles, Michael R Rickels, Michael A Tsoukas, Philip Raskin, Betul Hatipoglu, Donna Desjardins, Adrienne N Terry, Lakshmi G Singh, Georgia M Davis, Caleb Schmid, Jelena Kravarusic, Kasey Coyne, Luis Casaubon, Valerie Espinosa, Jaye K Jones, Kathleen Estrada, Samina Afreen, Camilla Levister, Grenye O'Malley, Selina L Liu, Sheryl Marks, Amy J Peleckis, Melissa-Rosina Pasqua, Vanessa Tardio, Corey Kurek, Ryan D Luker, Jade Churchill, Farbod Z Tajrishi, Ariel Dean, Brittany Dennis, Evelyn Fronczyk, Jennifer Perez, Shereen Mukhashen, Jasmeen Dhillon, Aslihan Ipek, Suzan Bzdick, Astrid Atakov Castillo, Marsha Driscoll, Xenia Averkiou, Cornelia V Dalton-Bakes, Adelyn Moore, Lin F Jordan, Amanda Lesniak, Jordan E Pinsker, Ravid Sasson-Katchalski, Tiffany Campos, Charles Spanbauer, Lauren Kanapka, Craig Kollman, Roy W Beck","doi":"10.1097/OGX.0000000000001463","DOIUrl":"10.1097/OGX.0000000000001463","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1801-1812) Automated insulin delivery (AID) systems improve outcomes in type 1 diabetes mellitus (T1DM), but their role in type 2 diabetes mellitus (T2DM) remains uncertain due to limited, small, or uncontrolled studies. Many patients achieve glycated hemoglobin (HbA1c) <7% with glucagon-like peptide 1 agonists or sodium-glucose cotransporter 2 inhibitors, but those who do not may benefit from AID.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"681-683"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/01.ogx.0001172288.00818.27
Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran
(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.
{"title":"Prenatal Screening for CMV Primary Infection: A Cost-Utility Model.","authors":"Gebrael El Hachem, Christian Renaud, Catherine McCarey, Soren Gantt, Fatima Kakkar, Marc Sab, Thomas G Poder, Isabelle Boucoiran","doi":"10.1097/01.ogx.0001172288.00818.27","DOIUrl":"10.1097/01.ogx.0001172288.00818.27","url":null,"abstract":"<p><p>(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"689-691"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/01.ogx.0001172280.42312.99
Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers
(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.
(摘自journal of obstetrics gynecology, 2025;104:839-849)妊娠期糖尿病(Gestational diabetes, GDM)是指妊娠期起病的高血糖,与不良结局和母体糖尿病的长期风险增加有关。筛查方案在国际上各不相同,一些国家只检测高危妊娠,但加拿大自2003年以来一直建议进行普遍筛查。
{"title":"Perinatal Outcomes Following Nonadherence to Guideline-Based Screening for Gestational Diabetes: A Population-Based Cohort Study.","authors":"Elizabeth Nethery, Kelly Pickerill, Luba Butska, Michelle Turner, Jennifer A Hutcheon, Patricia A Janssen, Laura Schummers","doi":"10.1097/01.ogx.0001172280.42312.99","DOIUrl":"10.1097/01.ogx.0001172280.42312.99","url":null,"abstract":"<p><p>(Abstracted from Acta Obstet Gynecol Scand 2025;104:839-849) Gestational diabetes mellitus (GDM), defined as high blood sugar onset in pregnancy, is associated with adverse outcomes and increased long-term maternal diabetes risk. Screening protocols vary internationally, with some countries testing only high-risk pregnancies, but Canada has recommended universal screening since 2003.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"683-685"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/OGX.0000000000001459
Karis Buford, Kenneth M Peters, Claus Riedl, Nagendra Nath Mishra, Wyndaele Jean Jacques, Sandor Lovasz, Rui Almeida Pinto, Lori Birder
(Abstracted from Neurourol Urodyn 2025, doi:10.1002/nau.70106) The chronic condition of bladder pain, pressure, and urinary symptoms without a clear cause is classified as interstitial cystitis or bladder pain syndrome (IC/BPS), and it affects large numbers of individuals globally. Presentation varies, but it can include debilitating pain and significantly decrease quality of life.
{"title":"Global Consensus on Interstitial Cystitis/Bladder Pain Syndrome: An Update on Therapeutic Treatments.","authors":"Karis Buford, Kenneth M Peters, Claus Riedl, Nagendra Nath Mishra, Wyndaele Jean Jacques, Sandor Lovasz, Rui Almeida Pinto, Lori Birder","doi":"10.1097/OGX.0000000000001459","DOIUrl":"10.1097/OGX.0000000000001459","url":null,"abstract":"<p><p>(Abstracted from Neurourol Urodyn 2025, doi:10.1002/nau.70106) The chronic condition of bladder pain, pressure, and urinary symptoms without a clear cause is classified as interstitial cystitis or bladder pain syndrome (IC/BPS), and it affects large numbers of individuals globally. Presentation varies, but it can include debilitating pain and significantly decrease quality of life.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"694-696"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/01.ogx.0001172300.43934.90
Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan
(Abstracted from Contraception 2025;149:110972) In the United States, depot medroxyprogesterone acetate (DMPA) is distributed in the subcutaneous (SC) formulation in prefilled, single-dose syringes; this format makes self-administration or administration by someone other than a clinician easy and accessible. This may improve contraceptive access by making the medication more available and not requiring a clinician visit for its administration.
{"title":"A Systematic Comparison of Implementation Strategies at Three U.S. Clinic Settings That Expanded Access to Self-administered Injectable Contraception.","authors":"Jennifer Karlin, Tammy Bennett, Leah Michael, Sally Rafie, Elise D Berlan","doi":"10.1097/01.ogx.0001172300.43934.90","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172300.43934.90","url":null,"abstract":"<p><p>(Abstracted from Contraception 2025;149:110972) In the United States, depot medroxyprogesterone acetate (DMPA) is distributed in the subcutaneous (SC) formulation in prefilled, single-dose syringes; this format makes self-administration or administration by someone other than a clinician easy and accessible. This may improve contraceptive access by making the medication more available and not requiring a clinician visit for its administration.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"699-701"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/OGX.0000000000001461
M M Van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-Theunissen
(Abstracted from Hum Reprod 2025 ;40(8):1485-1494) Embryonic development relies heavily on 1-carbon metabolism, which is influenced heavily by folate and vitamin B12. Both placental and embryonic and fetal development are affected, and previous research has shown supplementation with folic acid during early pregnancy reduces the prevalence of neural tube defects; some research has also shown that deficiencies in folate and vitamin B12 may be associated with adverse pregnancy outcomes such as preeclampsia and low birth weight.
{"title":"First Trimester Maternal Folate and Vitamin B12 Concentrations and Their Associations With First-Trimester Placental Growth: The Rotterdam Periconception Cohort.","authors":"M M Van Vliet, S Schoenmakers, S P Willemsen, K D Sinclair, R P M Steegers-Theunissen","doi":"10.1097/OGX.0000000000001461","DOIUrl":"10.1097/OGX.0000000000001461","url":null,"abstract":"<p><p>(Abstracted from Hum Reprod 2025 ;40(8):1485-1494) Embryonic development relies heavily on 1-carbon metabolism, which is influenced heavily by folate and vitamin B12. Both placental and embryonic and fetal development are affected, and previous research has shown supplementation with folic acid during early pregnancy reduces the prevalence of neural tube defects; some research has also shown that deficiencies in folate and vitamin B12 may be associated with adverse pregnancy outcomes such as preeclampsia and low birth weight.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"704-706"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/OGX.0000000000001462
Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y Kuo, Josune Zubicaray, Dayna Terrazas, Gráinne O'Toole, Maria Chitty-Lopez, Grace Choi, Eileen Nicoletti, Janel Long-Boyle, Augustine Fernandes, Kritika Chetty, Satiro De Oliveira, Crystal Banuelos, Jinhua Xu-Bayford, Antonella Lucía Bastone, Philipp John-Neek, Connie Jackson, Theodore B Moore, Kimberly Gilmour, Axel Schambach, Michael Rothe, Sanchali Kasbekar, Gayatri R Rao, Kinnari Patel, Gaurav Shah, Adrian J Thrasher, Juan A Bueren, Jonathan D Schwartz, Donald B Kohn
(Abstracted from N Engl J Med 2025;392:1698-1709) Leukocyte adhesion deficiency type I (LAD-I) is an autosomal recessive immune disorder marked by recurrent, life-threatening infections, with 25% to 39% mortality before age 2 years without curative therapy. Common symptoms include umbilical-cord complications, poorly healing cutaneous lesions, persistent leukocytosis, and periodontitis.
{"title":"Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.","authors":"Claire Booth, Julián Sevilla, Elena Almarza, Caroline Y Kuo, Josune Zubicaray, Dayna Terrazas, Gráinne O'Toole, Maria Chitty-Lopez, Grace Choi, Eileen Nicoletti, Janel Long-Boyle, Augustine Fernandes, Kritika Chetty, Satiro De Oliveira, Crystal Banuelos, Jinhua Xu-Bayford, Antonella Lucía Bastone, Philipp John-Neek, Connie Jackson, Theodore B Moore, Kimberly Gilmour, Axel Schambach, Michael Rothe, Sanchali Kasbekar, Gayatri R Rao, Kinnari Patel, Gaurav Shah, Adrian J Thrasher, Juan A Bueren, Jonathan D Schwartz, Donald B Kohn","doi":"10.1097/OGX.0000000000001462","DOIUrl":"10.1097/OGX.0000000000001462","url":null,"abstract":"<p><p>(Abstracted from N Engl J Med 2025;392:1698-1709) Leukocyte adhesion deficiency type I (LAD-I) is an autosomal recessive immune disorder marked by recurrent, life-threatening infections, with 25% to 39% mortality before age 2 years without curative therapy. Common symptoms include umbilical-cord complications, poorly healing cutaneous lesions, persistent leukocytosis, and periodontitis.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"687-689"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/01.ogx.0001172296.60790.17
Hope H Bauer, Maura A Schlussel, Emily A Hoffberg, Kasey M Palm, Stephen P Rhodes, Susan D Wherley, Margot Le Neveu, Sarah B Sears, Gabriella M Rustia, Adonis K Hijaz, Sangeeta T Mahajan, Anne G Sammarco, David Sheyn
(Abstracted from Obstet Gynecol 2025;146(2):285-292) Prolapse repair is one of the most common surgeries performed in adult women. An overwhelming majority (80%) of individuals who undergo pelvic organ prolapse repair are prescribed opioids postoperatively, and for many individuals, this is their first exposure to these substances.
{"title":"Personalized Prediction of Opioid Demand After Surgery for Pelvic Organ Prolapse: A Randomized Controlled Trial.","authors":"Hope H Bauer, Maura A Schlussel, Emily A Hoffberg, Kasey M Palm, Stephen P Rhodes, Susan D Wherley, Margot Le Neveu, Sarah B Sears, Gabriella M Rustia, Adonis K Hijaz, Sangeeta T Mahajan, Anne G Sammarco, David Sheyn","doi":"10.1097/01.ogx.0001172296.60790.17","DOIUrl":"10.1097/01.ogx.0001172296.60790.17","url":null,"abstract":"<p><p>(Abstracted from Obstet Gynecol 2025;146(2):285-292) Prolapse repair is one of the most common surgeries performed in adult women. An overwhelming majority (80%) of individuals who undergo pelvic organ prolapse repair are prescribed opioids postoperatively, and for many individuals, this is their first exposure to these substances.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"696-697"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145857622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1097/01.ogx.0001172304.52472.fb
Philippe Descamps, Samantha Dixon, Francesc Xavier Bosch Jose, Maria Kyrgiou, Joseph Monsonego, Ody Neisingh, Lananh Nguyen, Mairead O'Connor, Jennifer S Smith
(Abstracted from Int J Gynaecol Obstet 2024:166 Suppl 1:3-21) The availability of comprehensive health care services and cancer screening in high-income countries has greatly reduced the burden of certain cancers, such as cervical cancer. Although the burden has been significantly reduced, cervical cancer still represents a large health burden with high numbers of deaths attributed to it yearly across the world.
{"title":"Turning the Tide: Recommendations to Increase Cervical Cancer Screening Among Women Who Are Underscreened.","authors":"Philippe Descamps, Samantha Dixon, Francesc Xavier Bosch Jose, Maria Kyrgiou, Joseph Monsonego, Ody Neisingh, Lananh Nguyen, Mairead O'Connor, Jennifer S Smith","doi":"10.1097/01.ogx.0001172304.52472.fb","DOIUrl":"https://doi.org/10.1097/01.ogx.0001172304.52472.fb","url":null,"abstract":"<p><p>(Abstracted from Int J Gynaecol Obstet 2024:166 Suppl 1:3-21) The availability of comprehensive health care services and cancer screening in high-income countries has greatly reduced the burden of certain cancers, such as cervical cancer. Although the burden has been significantly reduced, cervical cancer still represents a large health burden with high numbers of deaths attributed to it yearly across the world.</p>","PeriodicalId":19409,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"80 11","pages":"702-704"},"PeriodicalIF":3.6,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145452497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}